US OptionsDetailed Quotes
DHX241220C3000
- 0.00
- 0.000.00%
15min DelayClose Nov 22 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover0.00%IV73.41%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.77Leverage Ratio--Theta--Rho--Eff Leverage--Vega
DHI Group Stock Discussion
Sign in to post a comment
$Westwood Holdings (WHG.US)$ $FTC Solar (FTCI.US)$ $Mesa Air Group (MESA.US)$ $Veritone (VERI.US)$ $Vera Bradley (VRA.US)$ $Above Food Ingredients (ABVE.US)$ $DHI Group (DHX.US)$ $MediaCo (MDIA.US)$ $Vicinity Motor (VEV.US)$ $Climb Bio (CLYM.US)$ $A2Z Cust2Mate Solutions (AZ.US)$ $Veea Inc (VEEA.US)$ $Tevogen Bio Holdings (TVGN.US)$
5
1
$DHI Group (DHX.US)$ Now, after re-evaluation, I am positive in this stock, and if it slides to $1.8-2, I shall add more. I have this stock in my portfolio and alocated an additional 1% if there is any further correction. Best for long term, short erm it will be range bound.
My research and analysis are not advice or recommendations. It's for information and knowledge purposes only. Any research , analysis, information, or other material received should not be construed...
My research and analysis are not advice or recommendations. It's for information and knowledge purposes only. Any research , analysis, information, or other material received should not be construed...
3
$DHI Group (DHX.US)$ Great momentum and fundamental play but no fuel to break the resistance @$2.8 with huge volume. I think it wll test lower level $2 before making next big move.
DHI Group's high P/E ratio is alarming due to its falling earnings and bleak growth forecast. Investors expecting a business revival may be let down if the P/E aligns with the negative growth. The anticipated future earnings may not sustain the high P/E, risking shareholders' investments and potential investors might overpay.
1
Gainers:
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...
19
$DHI Group (DHX.US)$ pump is coming
No comment yet
Bigmoney Dreamer : Thx!Which tool you use to find them ?